Insider Transactions in Q3 2023 at Longeveron Inc. (LGVN)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2023
|
Joshua Hare Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.06%
|
$15,000
$3.0 P/Share
|
|
Sep 20
2023
|
Paul T Lehr General Counsel, Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+1.37%
|
$6,000
$3.0 P/Share
|
|
Sep 12
2023
|
Joshua Hare Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+0.38%
|
$90,000
$3.0 P/Share
|
|
Sep 12
2023
|
Lisa Locklear Chief Financial Officer |
BUY
Exercise of out-of-the-money derivative securities
|
Direct |
5,000
+10.0%
|
$15,000
$3.0 P/Share
|
|
Sep 12
2023
|
Mohamed Wa'El Ahmed Hashad Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+17.37%
|
$30,000
$3.0 P/Share
|
|
Sep 08
2023
|
Rock Soffer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+4.1%
|
$90,000
$3.0 P/Share
|
|
Sep 01
2023
|
Mohamed Wa'El Ahmed Hashad Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,323
-10.32%
|
$8,646
$2.64 P/Share
|
|
Aug 18
2023
|
Mohamed Wa'El Ahmed Hashad Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,292
-9.29%
|
$12,876
$3.25 P/Share
|
|
Aug 18
2023
|
Nataliya Agafonova Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,081
-10.27%
|
$9,243
$3.36 P/Share
|
|
Aug 18
2023
|
Paul T Lehr General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
767
-0.54%
|
$2,301
$3.25 P/Share
|
|
Jul 31
2023
|
Lisa Locklear Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+50.0%
|
-
|
|
Jul 24
2023
|
Nataliya Agafonova Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+50.0%
|
-
|